Gelteq Limited (GELS)
Gelteq will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
1,300,000
Deal Size
$6.50M
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | 47.19M |
| Revenue (ttm) | 353 |
| Net Income (ttm) | -1.68M |
| Shares Out | 9.44M |
| EPS (ttm) | -0.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About GELS
Gelteq is a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. A “white label” gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals — for pets, sports, pharmaceutical (ph... [Read more]
Industry Health Care
Sector Pharmaceuticals
Founded 2018
Employees 5
Stock Exchange NASDAQ
Ticker Symbol GELS
News
Gelteq IPO Registration Document (F-1)
Gelteq has filed to go public with an IPO on the NASDAQ.
1 year ago - SEC